Maintenance therapy with infliximab—an anti-tumor necrosis factor agent—is standard treatment for moderate to severe pediatric inflammatory bowel disease (IBD).
Patients with fecal incontinence (FI) and loose stool can decrease their likelihood of experiencing symptoms if they follow a diet low in fermentable oligo-, di-, and...
At ACG 2018, hepatologist Mitchell Shiffman, MD, outlined current concerns and special populations in the treatment of hepatitis C virus following the emergence of DAAs.
Researchers performed small RNA sequencing of colon tissue from more than 100 individuals to better understand cellular mechanisms that create heterogeneity in CD.
In a plenary session at ACG 2018, Dr Adeeti Chiplunker from Washington University discussed her research on the effect of magnetic resonance enterography on the management of small bowel Crohn disease. ...
Researchers at Vanderbilt University Medical Center conducted a retrospective study among more than 400 patients with inflammatory bowel disease to evaluate adherence to injectable biologic therapy.
Researchers evaluated data of more than 200 patients to see whether a thrombopoietin receptor agonist could serve as an alternative to blood transfusion in thrombocytopenia and chronic liver disease.
